Top

BMC Infectious Diseases

Published in:

01-12-2021 | Research

Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis

Authors: Joseph L. Servadio, Claudia Muñoz-Zanzi, Matteo Convertino

Published in: BMC Infectious Diseases | Issue 1/2021

Abstract

Background

Case fatality risk (CFR), commonly referred to as a case fatality ratio or rate, represents the probability of a disease case being fatal. It is often estimated for various diseases through analysis of surveillance data, case reports, or record examinations. Reported CFR values for Yellow Fever vary, offering wide ranges. Estimates have not been found through systematic literature review, which has been used to estimate CFR of other diseases. This study aims to estimate the case fatality risk of severe Yellow Fever cases through a systematic literature review and meta-analysis.

Methods

A search strategy was implemented in PubMed and Ovid Medline in June 2019 and updated in March 2021, seeking reported severe case counts, defined by fever and either jaundice or hemorrhaging, and the number of those that were fatal. The searches yielded 1,133 studies, and title/abstract review followed by full text review produced 14 articles reporting 32 proportions of fatal cases, 26 of which were suitable for meta-analysis. Four studies with one proportion each were added to include clinical case data from the recent outbreak in Brazil. Data were analyzed through an intercept-only logistic meta-regression with random effects for study. Values of the I² statistic measured heterogeneity across studies.

Results

The estimated CFR was 39 % (95 % CI: 31 %, 47 %). Stratifying by continent showed that South America observed a higher CFR than Africa, though fewer studies reported estimates for South America. No difference was seen between studies reporting surveillance data and studies investigating outbreaks, and no difference was seen among different symptom definitions. High heterogeneity was observed across studies.

Conclusions

Approximately 39 % of severe Yellow Fever cases are estimated to be fatal. This study provides the first systematic literature review to estimate the CFR of Yellow Fever, which can provide insight into outbreak preparedness and estimating underreporting.

Available only for authorised users

Wong JY, Kelly H, Ip DKM, Wu JT, Leung GM, Cowling BJ. Case fatality risk of influenza a (H1N1pdm09): a systematic review. Epidemiology. 2013;24(6):830–41.PubMedCrossRef

Kelly H, Cowling BJ, Case Fatality. Epidemiology. 2013;24(4):622–3.PubMedCrossRef

Salama M, Amitai Z, Lustig Y, Mor Z, Weiberger M, Chowers M, et al. Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases. Travel Med Infect Dis. 2019;1:41–5.CrossRef

Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–13.PubMedCrossRef

Self JL, Conrad A, Stroika S, Jackson A, Whitlock L, Jackson KA, et al. Multistate outbreak of listeriosis associated with packaged leafy green salads, United States and Canada, 2015–2016. Emerg Infect Dis. 2019;25(8):1461–8.PubMedPubMedCentralCrossRef

Cromer D, Van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363–71.PubMedCrossRef

Yu AT, Amin N, Rahman MW, Gurley ES, Rahman KM, Luby SP. Case-fatality ratio of blood culture-confirmed typhoid fever in Dhaka, Bangladesh. J Infect Dis. 2018;218(suppl_4):S222-6.PubMedPubMedCentralCrossRef

Reich NG, Lessler J, Cummings DAT, Brookmeyer R. Estimating absolute and relative case fatality ratios from infectious disease surveillance data. Biometrics. 2012;68(2):598–606.PubMedPubMedCentralCrossRef

Elandt-Johnson RC. Definition of rates: some remarks on their use and misuse. Am J Epidemiol. 1975;102(4):267–71.PubMedCrossRef

10.

Debnath F, Ponnaiah M, Acharya P. Dengue fever in a municipality of West Bengal, India, 2015: an outbreak investigation. Indian J Public Health. 2017;61(4):239–42.PubMedCrossRef

11.

Jia N, Feng D, Fang LQ, Richardus JH, Han XN, Cao WC, et al. Case fatality of SARS in mainland China and associated risk factors. Trop Med Int Heal. 2009;14(SUPPL. 1):21–7.CrossRef

12.

Yu H, Cowling BJ, Feng L, Lau EHY, Liao Q, Tsang TK, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013;13(9887):138–45.CrossRef

13.

Gao Z, Parhar A, Gallant V, Heffernan C, Ahmed R, Egedahl ML, et al. Apopulation-based study of tuberculosis case fatality in Canada: do aboriginal peoples fare less well? Int J Tuberc Lung Dis. 2015;19(7):772–9.PubMedCrossRef

14.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015;9(7):e0003846.PubMedPubMedCentralCrossRef

15.

Johansson MA, Vasconcelos PFC, Staples JE. The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases. Trans R Soc Trop Med Hyg. 2014;108(8):482–7.PubMedCrossRef

16.

Uche IV, MacLennan CA, Saul A. A systematic review of the incidence, risk factors and case fatality rates of Invasive Nontyphoidal Salmonella (iNTS) disease in Africa (1966 to 2014). PLoS Negl Trop Dis. 2017. https://doi.org/10.1371/journal.pntd.0005118.CrossRefPubMedPubMedCentral

17.

Tan B, Wong JJM, Sultana R, Koh JCJW, Jit M, Mok YH, et al. Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(4):352–62.PubMedPubMedCentralCrossRef

18.

Kenmoe S, Demanou M, Bigna JJ, Nde Kengne C, Fatawou Modiyinji A, Simo FBN, et al. Case fatality rate and risk factors for Nipah virus encephalitis: a systematic review and meta-analysis. J Clin Virol. 2019;117:19–26.PubMedCrossRef

19.

Woldeamanuel YW, Andemeskel AT, Kyei K, Woldeamanuel MW, Woldeamanuel W. Case fatality of adult tetanus in Africa: systematic review and meta-analysis. J Neurol Sci. 2016;368:292–9.PubMedCrossRef

20.

Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob Heal. 2019;7(4):e472-81.CrossRef

21.

Szabo SM, Samp JC, Walker DR, Lane S, Cline SK, Gooch KL, et al. Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic review. Ann Hepatol. 2015;14(5):618–30.PubMedCrossRef

22.

Couto-Lima D, Madec Y, Bersot MI, Campos SS, de Motta MA, dos Santos FBDFB, et al. Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations. Sci Rep. 2017;7(1):4848.PubMedPubMedCentralCrossRef

23.

World Health Organization. Yellow fever [Internet]. Fact Sheets. 2018. https://doi.org/http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever. Accessed 21 Jul 2018.

24.

Gubler DJ. Pandemic yellow fever: a potential threat to global health via travelers. J Travel Med. 2018. https://doi.org/10.1093/jtm/tay097.CrossRefPubMed

25.

Wilder-Smith A, Leong WY. Importation of yellow fever into China: assessing travel patterns. J Travel Med. 2017. https://doi.org/10.1093/jtm/tax008.CrossRefPubMed

26.

Centers for Disease Control and Prevention. Yellow Fever [Internet]. Global Health - Newsroom. 2018. https://doi.org/https://www.cdc.gov/globalhealth/newsroom/topics/yellowfever/index.html. Accessed 9 Sep 2020.

27.

Liu Y, Rocklöv J. What is the reproductive number of yellow fever? J Travel Med. 2020. https://doi.org/10.1093/jtm/taaa156.CrossRefPubMedPubMedCentral

28.

Centers for Disease Control and Prevention. Yellow Fever [Internet]. https://doi.org/https://www.cdc.gov/yellowfever/symptoms/index.html. Accessed 25 Feb 2019.

29.

Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Heal Inf Libr J. 2009;1(2):91–108.CrossRef

30.

World Health Organization. Yellow fever [Internet]. 2019. https://doi.org/https://www.who.int/news-room/fact-sheets/detail/yellow-fever. Accessed 17 Apr 2021.

31.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009. https://doi.org/10.1371/journal.pmed.1000100.CrossRefPubMedPubMedCentral

32.

PRISMA Checklist [Internet]. 2015. https://doi.org/http://prisma-statement.org/PRISMAStatement/Checklist.aspx. Accessed 1 May 2020.

33.

Devito NJ, Goldacre B. Catalogue of bias: publication bias. BMJ Evidence-Based Med. 2019;24(1):53–4.CrossRef

34.

Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.PubMedCrossRef

35.

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;15(11):1539–58.CrossRef

36.

World Health Organization. Yellow fever in Africa and South America. Relev Epidemiol Hebd 2008. 2006;83(8):60–76.

37.

Wamala JF, Malimbo M, Okot CL, Atai-Omoruto AD, Tenywa E, Miller JR, et al. Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010-January 2011. Int J Infect Dis. 2012;16(7):e536-42.PubMedCrossRef

38.

de Filippis AMB, Nogueira RMR, Schatzmayr HG, Tavares DS, Jabor AV, Diniz SCM, et al. Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus. J Med Virol. 2002;68(4):620–7.PubMedCrossRef

39.

Tuboi SH, Costa ZGA, da Costa Vasconcelos PF, Hatch D. Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002. Trans R Soc Trop Med Hyg. 2007;101(2):169–75.PubMedCrossRef

40.

Jones EM, Wilson DC. Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau, Nigeria. Bull World Health Organ. 1972;46(5):653–7.PubMedPubMedCentral

41.

World Health Organization. Weekly epidemiological record. 1993;68(11):77–8.

42.

Ingelbeen B, Weregemere NA, Noel H, Tshapenda GP, Mossoko M, Nsio J, et al. Urban yellow fever outbreak-Democratic Republic of the Congo, 2016: Towards more rapid case detection. PLoS Negl Trop Dis. 2018;12(12):e0007029.PubMedPubMedCentralCrossRef

43.

Monath TP, Craven RB, Adjukiewicz A, Germain M, Francy DB, Ferrara L, et al. Yellow fever in the Gambia, 1978–1979: Epidemiologic aspects with observations on the occurrence of Orungo virus infections. Am J Trop Med Hyg. 1980;29(5):912–28.PubMedCrossRef

44.

Yellow fever in Africa and Central and South America, 2008–2009. Relev Epidemiol Hebd. 2011;86(4):25–36.

45.

Agadzi VK, Boatin BA, Appawu MA, Mingle JA, Addy PA. Yellow fever in Ghana, 1977-80. Bull World Health Organ. 1984;62(4):577–83.PubMedPubMedCentral

46.

De Cock KM, Monath TP, Nasidi A, Tukei PM, Enriquez J, Lichfield P, et al. Epidemic yellow fever in eastern Nigeria, 1986. Lancet (London, England). 1988;1(8586):630–3.CrossRef

47.

Nasidi A, Monath TP, DeCock K, Tomori O, Cordellier R, Olaleye OD, et al. Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg. 1989;83(3):401–6.PubMedCrossRef

48.

Cunha MDP, Duarte-Neto AN, Pour SZ, Ortiz-Baez AS, Černý J, de Pereira BB, et al. Origin of the São Paulo Yellow Fever epidemic of 2017–2018 revealed through molecular epidemiological analysis of fatal cases. Sci Rep. 2019;9(1):20418.PubMedPubMedCentralCrossRef

49.

Otshudiema JO, Ndakala NG, Mawanda EK, Tshapenda GP, Kimfuta JM, Nsibu L-RN, et al. Yellow Fever Outbreak—Kongo Central Province, Democratic Republic of the Congo, August 2016. MMWR Morb Mortal Wkly Rep. 2017;31(12):335–8.CrossRef

50.

de Ávila RE, José Fernandes H, Barbosa GM, Araújo AL, Gomes TCC, Barros TG, et al. Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil. Int J Infect Dis. 2020;93:90–7.PubMedCrossRef

51.

Ribeiro AF, Cavalin RF, Abdul Hamid Suleiman JM, Alves da Costa J, Januaria de Vasconcelos M, Sant’Ana Málaque CM, et al. Yellow Fever: Factors Associated with Death in a Hospital of Reference in Infectious Diseases, São Paulo, Brazil, 2018. Am J Trop Med Hyg. 2019;101(1):180–8.PubMedPubMedCentralCrossRef

52.

Ho Y-L, Joelsons D, Leite GFC, Malbouisson LMS, Song ATW, Perondi B, et al. Severe Yellow Fever in Brazil: clinical characteristics and management. J Travel Med. 2019. https://doi.org/10.1093/jtm/taz040.CrossRefPubMed

53.

Kallas EG, D’Elia Zanella LGFAB, Moreira CH V, Buccheri R, Diniz GBF, Castiñeiras ACP, et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis. 2019;19(7):750–8.PubMedCrossRef

54.

Zhao YY, Jin H, Zhang XF, Wang B. Case-fatality of hand, foot and mouth disease associated with EV71: A systematic review and meta-analysis. Epidemiol Infect. 2015;143(14):3094–102.PubMedCrossRef

55.

Pieters Z, Saad NJ, Antillón M, Pitzer VE, Bilcke J. Case Fatality Rate of Enteric Fever in Endemic Countries: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018;67(4):628–38.PubMedPubMedCentralCrossRef

56.

Mutebi JP, Barrett ADT. The epidemiology of yellow fever in Africa. Microbes Infect. 2002;4(14):1459–68.PubMedCrossRef

57.

Barrett ADT, Higgs S. Yellow Fever: a disease that has yet to be conquered. Annu Rev Entomol. 2007;52(1):209–29.PubMedCrossRef

58.

Auguste AJ, Lemey P, Pybus OG, Suchard MA, Salas RA, Adesiyun AA, et al. Yellow Fever virus maintenance in Trinidad and its dispersal throughout the Americas. J Virol. 2010;84(19):9967–77.PubMedPubMedCentralCrossRef

59.

Gardner CL, Ryman KD. Yellow fever: a reemerging threat. Clin Lab Med. 2010;30(1):237–60.PubMedPubMedCentralCrossRef

60.

Jin H, Zhao Y, Zhang X, Wang B, Liu P. Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis. Epidemiol Infect. 2016;144(10):2098–106.PubMedCrossRef

61.

Nyakarahuka L, Kankya C, Krontveit R, Mayer B, Mwiine FN, Lutwama J, et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect Dis. 2016;16(1):708.PubMedPubMedCentralCrossRef

62.

Rota PA, Moss WJ, Takeda M, De Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Prim. 2016 Jul 14;2(1):1–16.

63.

Symptoms, diagnosis, & treatment [Internet]. https://doi.org/https://www.cdc.gov/yellowfever/symptoms/index.html. Accessed 16 Apr 2021.

64.

Woldeamanuel YW, Girma B. A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa. J Neurol. 2014;261(5):851–65.PubMedCrossRef

65.

Rogers DJ, Wilson AJ, Hay SI, Graham AJ. The global distribution of yellow fever and dengue. Adv Parasitol. 2006;62:181–220.PubMedPubMedCentralCrossRef

66.

World Health Organization. Situation report: Yellow Fever. Geneva: World Health Organization; 2016.

67.

Yellow fever in Africa and the Americas, 2016. Relev Epidemiol Hebd. 2017;92(32):442–52.

68.

Vasconcelos PFC, Rodrigues SG, Degallier N, Moraes MAP, Travassos Da Rosa JFS, Rosa Travassos Da, et al. An epidemic of sylvatic yellow fever in the southeast region of Maranhao State, Brazil, 1993–1994: epidemiologic and entomologic findings. Am J Trop Med Hyg. 1997;57(2):132–7.PubMedCrossRef

69.

Yellow fever in Africa and South America, 2015. Relev Epidemiol Hebd. 2016;91(32):381–8.

70.

Pinheiro FP, Travassos da Rosa AP, Moraes MA, Almeida Neto JC, Camargo S, Filgueiras JP. An epidemic of yellow fever in central Brazil. 1972–1973. I. Epidemiological studies. Am J Trop Med Hyg. 1978;27(1 Pt 1):125–32.PubMedCrossRef

71.

Anonymous. Yellow fever in 1989 and 1990. Relev Epidemiol Hebd. 1992;67(33):245–51.

72.

Shearer FM, Longbottom J, Browne AJ, Pigott DM, Brady OJ, Kraemer MUGG, et al. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis. Lancet Glob Heal. 2018;6(3):e270-8.CrossRef

73.

Karlberg J, Chong DSY, Lai WYY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–31.PubMedCrossRef

Title: Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis
Authors: Joseph L. Servadio
Claudia Muñoz-Zanzi
Matteo Convertino
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-021-06535-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Etiology of diarrhea by multiplex polymerase chain reaction among young children in the United Arab Emirates: a case-control study

Seizure in HIV-infected patients: clinical presentation, cause and treatment outcome in Ethiopia—a retrospective study

Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study

Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice

Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report

Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page